ARG1D Foundation Files Petition Urging Aeglea Biotherapeutics to Reinstate Life-Saving Drug Following Abrupt Withdrawal
ARG1D Foundation Urges Aeglea Biotherapeutics to Reinstate Life-Saving Drug Following Abrupt Withdrawal to Clinical Trial Patients in the United States SEATTLE, WASHINGTON, UNITED STATES , April 21, 2023 /EINPresswire.com/ -- The Arginase 1 Deficiency …